Detail akcie ClearPoint Neuro Rg online

Business Summary: ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. It provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. It provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide. It also offers IRRAflow active fluid-exchange system.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Clearpoint Neuro Inc revenues increased 12% to $26.6M. Net loss increased 31% to $17.8M. Revenues reflect Products: Functional neurosurgery segment increase of 37% to $10.1M, Products: Biologics and drug delivery segment increase of 15% to $4.9M. Higher net loss reflects General and administrative expenses increase of 33% to $7.6M (expense).